Detalles de la búsqueda
1.
CD4/CD8 Ratio Outcome According to the Class of the Third Active Drug in Antiretroviral Therapy Regimens: Results From the Quebec Human Immunodeficiency Virus Cohort Study.
Clin Infect Dis
; 76(11): 1879-1888, 2023 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36722329
2.
Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis.
J Hepatol
; 67(4): 801-808, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28527666
3.
Impact of previous HIV resistance and virologic failures on virologic outcome following a switch to dolutegravir with 2 NRTIs among people living with HIV.
Medicine (Baltimore)
; 99(47): e23335, 2020 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33217873
4.
Treatment Switch to Dolutegravir With 2 Nucleoside Reverse-Transcriptase Inhibitors (NRTI) in Comparison to Continuation With Protease Inhibitor/Ritonavir Among Patients With Human Immunodeficiency Virus at Risk for Prior NRTI Resistance: A Cohort Analysis of Real-World Data.
Open Forum Infect Dis
; 7(11): ofaa404, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33204746
5.
Nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV monoinfected patients.
AIDS
; 30(17): 2635-2643, 2016 11 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-27603289
6.
Incidence and predictors of hepatic steatosis and fibrosis by serum biomarkers in a large cohort of human immunodeficiency virus mono-infected patients.
Open Forum Infect Dis
; 2(1): ofv015, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26034765
Resultados
1 -
6
de 6
1
Próxima >
>>